-
1
-
-
34247125144
-
Mast-cell sarcoma of the tibia
-
DOI 10.1136/jcp.2006.040857
-
Brcić L, Vuletić LB, Stepan J, et al. Mast-cell sarcoma of the tibia. J Clin Pathol 2007;60:424-5. (Pubitemid 46596565)
-
(2007)
Journal of Clinical Pathology
, vol.60
, Issue.4
, pp. 424-425
-
-
Brcic, L.1
Vuletic, L.B.2
Stepan, J.3
Bonevski, A.4
Jakovljevic, G.5
Gasparov, S.6
Marjanovic, K.7
Seiwerth, S.8
-
3
-
-
0032838574
-
Mast cell sarcoma with tissue eosinophilia arising in the ascending colon
-
Kojima M, Nakamura S, Itoh H, et al. Mast cell sarcoma with tissue eosinophilia arising in the ascending colon. Mod Pathol 1999;12:739-43. (Pubitemid 29354889)
-
(1999)
Modern Pathology
, vol.12
, Issue.7
, pp. 739-743
-
-
Kojima, M.1
Nakamura, S.2
Itoh, H.3
Ohno, Y.4
Masawa, N.5
Joshita, T.6
Suchi, T.7
-
4
-
-
0035101403
-
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy
-
DOI 10.1097/00043426-200102000-00014
-
Guenther PP, Huebner A, Sobottka SB, et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J Pediatr Hematol Oncol 2001;23:134-8. (Pubitemid 32162678)
-
(2001)
Journal of Pediatric Hematology/Oncology
, vol.23
, Issue.2
, pp. 134-138
-
-
Guenther, P.P.1
Huebner, A.2
Sobottka, S.B.3
Neumeister, V.4
Weissbach, G.5
Todt, H.6
Parwaresch, R.7
-
5
-
-
0038001490
-
Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma
-
DOI 10.1097/00000478-200307000-00019
-
Chott A, Guenther P, Huebner A, et al. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma. Am J Surg Pathol 2003;27:1013-19. (Pubitemid 36758906)
-
(2003)
American Journal of Surgical Pathology
, vol.27
, Issue.7
, pp. 1013-1019
-
-
Chott, A.1
Guenther, P.2
Huebner, A.3
Selzer, E.4
Parwaresch, R.M.5
Horny, H.-P.6
Valent, P.7
-
6
-
-
33747336257
-
KIT Mutations in Mastocytosis and Their Potential as Therapeutic Targets
-
DOI 10.1016/j.iac.2006.05.003, PII S0889856106000506, Mast Cells and Masyocytosis
-
Gotlib J. KIT mutations in mastocytosis and their potential as therapeutic targets. Immunol Allergy Clin North Am 2006;26:575-92. (Pubitemid 44247535)
-
(2006)
Immunology and Allergy Clinics of North America
, vol.26
, Issue.3
, pp. 575-592
-
-
Gotlib, J.1
-
7
-
-
0038731316
-
Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816VKit is resistant
-
Frost MJ, Ferrao PT, Hughes TP, et al. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther 2002;1:1115-24.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 1115-1124
-
-
Frost, M.J.1
Ferrao, P.T.2
Hughes, T.P.3
-
8
-
-
0036493872
-
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
-
DOI 10.1182/blood.V99.5.1741
-
Ma Y, Zeng S, Metcalfe DD, et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002;99:1741-4. (Pubitemid 34533049)
-
(2002)
Blood
, vol.99
, Issue.5
, pp. 1741-1744
-
-
Ma, Y.1
Zeng, S.2
Metcalfe, D.D.3
Akin, C.4
Dimitrijevic, S.5
Butterfield, J.H.6
McMahon, G.7
Jack, L.B.8
|